Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ascend Wellness Holdings (AAWH) Cash & Equivalents (2020 - 2025)

Ascend Wellness Holdings (AAWH) has 6 years of Cash & Equivalents data on record, last reported at $87.3 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 33.69% year-over-year to $87.3 million; the TTM value through Sep 2025 reached $87.3 million, up 33.69%, while the annual FY2024 figure was $88.3 million, 21.72% up from the prior year.
  • Cash & Equivalents reached $87.3 million in Q3 2025 per AAWH's latest filing, down from $95.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $204.5 million in Q3 2021 and bottomed at $62.6 million in Q1 2021.
  • Average Cash & Equivalents over 5 years is $97.2 million, with a median of $87.3 million recorded in 2025.
  • Peak YoY movement for Cash & Equivalents: soared 9931.03% in 2021, then tumbled 55.31% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $155.5 million in 2021, then plummeted by 52.31% to $74.1 million in 2022, then fell by 2.21% to $72.5 million in 2023, then increased by 21.72% to $88.3 million in 2024, then fell by 1.11% to $87.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $87.3 million in Q3 2025, $95.3 million in Q2 2025, and $100.0 million in Q1 2025.